In a bold trade maneuver, on “liberation day,” US President Donald Trump announced a 26% reciprocal tariff on Indian goods, triggering a swift reaction in global and domestic markets. India’s Nifty dropped sharply, mid- and small-cap indices slipped into bear zones, and uncertainty dominated headlines.

But here’s the contrarian insight — this might just be India’s moment to lead.

At INVasset PMS, we believe such macro tremors often pave the way for strategic investing. While the surface may look volatile, the underlying structure favors India.

India’s Tariff Edge: The Breakdown

Trump’s tariff regime spared no one — but it hit some harder than others. And India now stands competitively better off:

A ₹100 item from India will now land in the U.S. at ₹126. The same from China will cost ₹154. That’s a 22% pricing edge. In key sectors — electronics, auto components, garments, pharmaceuticals — this advantage is critical.

Winners, Watchlists & Volatility Plays

Based on evolving tariff structures and global order books, here’s how the sectors align:

✅ Pharma

• U.S. tariffs: 0% (exempt)

• ~$9B of annual exports unaffected

• Strong export tailwind for companies with ANDA pipelines

✅ IT Services

• Immune from tariff impact

• Rupee depreciation supports margin expansion

• Cross-border digital services to benefit from global cost rationalization

? Textiles & Apparel

• Tariff: 26% (lower than Vietnam & Bangladesh)

• Gaining ground in U.S. fast-fashion sourcing

• Requires volume & branding to scale globally

⚠️ Gems, Jewellery & Seafood

• Margin-sensitive, vulnerable to buyer shifts

• Demand compression likely, especially in low-end luxury

? Specialty Chemicals & Electronics

• Higher tariffs absorbed better than China

• India positioned to gain from supply chain diversification

Macro Tailwinds: India’s Resilience in Motion

Markets may be noisy, but the macro trends supporting India are clear and powerful:

• Brent crude below $70: lower import bill, contained inflation

• Dollar Index below 103: easing USD strength = better EM flows

• U.S. 10Y bond yields down: less appeal for U.S. bonds, more for EM equities

• Gold/silver prices correcting: global inflation easing

• FII rotation from China to India: India becoming the go-to EM bet

These elements, combined with India’s stable fundamentals, create an ideal setting for long-term equity participation.

What Is INVasset PMS Doing?

As a quant-based, SEBI-registered PMS, we rely on data, not emotion. Our strategy is built to adapt in real-time.

We continue to strengthen portfolios around themes like:

• Contract Manufacturing & CDMO

• Hospitals & Diagnostics

• Capital Market Infrastructure

• Domestic Consumption: Both Staples and Aspirational

• Blue-Chip Value Leaders

And if global volatility rises further, we retain the ability to shift 100% into cash — a feature not available in mutual funds. We’ve successfully done this twice in the past five years, protecting capital and preserving gains during selloffs.

India’s Diplomacy: Trade Deals in the Pipeline

India’s policy response has been mature. Talks are underway with:

• United States – a reciprocal deal under discussion

• Japan, Vietnam & the EU – expanding low-tariff corridors

• Incentives for MSMEs and PLI – to cushion short-term shocks

Most observers expect tariff revisions or sectoral exemptions by late 2025.

Investor Takeaway: Don't Miss the Shift

• This isn’t a repeat of 2008 or 2020

• India’s consumption-led model (70%+ of GDP) is a buffer

• Export pressure is real — but it is selective, not systemic

• Quality companies will not only survive — they will thrive